168 related articles for article (PubMed ID: 24194935)
1. Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.
Valletti A; Gigante M; Palumbo O; Carella M; Divella C; Sbisà E; Tullo A; Picardi E; D'Erchia AM; Battaglia M; Gesualdo L; Pesole G; Ranieri E
PLoS One; 2013; 8(10):e78452. PubMed ID: 24194935
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
3. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation.
Ha KCh; Coulombe-Huntington J; Majewski J
BMC Genomics; 2009 Nov; 10():519. PubMed ID: 19909511
[TBL] [Abstract][Full Text] [Related]
5. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
6. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
8. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
[TBL] [Abstract][Full Text] [Related]
9. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
[TBL] [Abstract][Full Text] [Related]
10. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
11. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.
Malouf GG; Su X; Yao H; Gao J; Xiong L; He Q; Compérat E; Couturier J; Molinié V; Escudier B; Camparo P; Doss DJ; Thompson EJ; Khayat D; Wood CG; Yu W; Teh BT; Weinstein J; Tannir NM
Clin Cancer Res; 2014 Aug; 20(15):4129-40. PubMed ID: 24899691
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
15. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.
Langer W; Sohler F; Leder G; Beckmann G; Seidel H; Gröne J; Hummel M; Sommer A
BMC Genomics; 2010 Nov; 11():676. PubMed ID: 21118496
[TBL] [Abstract][Full Text] [Related]
16. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
17. The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
Mizutani A; Koinuma D; Seimiya H; Miyazono K
Oncogene; 2016 Jul; 35(27):3514-23. PubMed ID: 26522722
[TBL] [Abstract][Full Text] [Related]
18. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.
Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P
Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.
Osanto S; Qin Y; Buermans HP; Berkers J; Lerut E; Goeman JJ; van Poppel H
PLoS One; 2012; 7(6):e38298. PubMed ID: 22745662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]